PXDT

Pixie Dust Technologies
PXDT

$1.56
4.7%

Market Cap: $23.2M

 

About: Pixie Dust Technologies Inc is the serial incubator that provides solutions for social trust and faith. The company develops computer technology that blends into the world by using interface technology that utilizes sound and light. Its products include Sound Hug: A device that allows one to enjoy music with light and vibration by hugging it, Sonorepro; a hair care device equipped with non-contact oscillating pressure stimulation technology born from ultrasonic research, Vuevo; A service that visualizes conversations between multiple people and connects differences in hearing, and kikippa; gamma wave sound care device.

Employees: 80

0
Funds holding %
of 6,728 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

0% more funds holding

Funds holding: 3 [Q1] → 3 (+0) [Q2]

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

0.13% less ownership

Funds ownership: 0.52% [Q1] → 0.4% (-0.13%) [Q2]

67% less capital invested

Capital invested by funds: $268K [Q1] → $88.8K (-$180K) [Q2]

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Research analyst outlook

We haven’t received any recent analyst ratings for PXDT.

Financial journalist opinion

Neutral
PRNewsWire
7 months ago
Pixie Dust Technologies Reports First-Half Fiscal Year 2024 Financial Results
NEW YORK and TOKYO , Feb. 12, 2024 /PRNewswire/ - Pixie Dust Technologies, Inc. (NasdaqCM: PXDT) (the "Company"), a Japanese technology company focused on commercializing innovative products and materials utilizing proprietary wave technology, reported financial results for the six months ended October 31, 2023. Recent Operational Highlights Introduced a one-time purchase model for its proprietary speaker kikippa, in addition to the current recurring subscription model Announced Company-sponsored experiment on the SonoRepro™ product, conducted by Dr. Akinobu Miyata, Director of Miyata Medical Clinic, in collaboration with the Japan Clinical Trial Association Exhibited at CES 2024 held in Las Vegas, NV and received the Innovation Award for its iwasemi™ RC-α product Announced collaborative research agreement with Tohoku University School of Medicine for the purpose of developing and commercializing certain non-pharmaceutical skin disease treatments using wave control technology Awarded the 2023 Good Design Award for the kikippa speaker Six Months Ended October 31, 2023 Financial Results The Company's financial statements for the six months ended October 31, 2023 and the related notes, and related management's discussion and analysis of the Company's financial condition and results of operations can be found in the Company's Form 6-K filed with the SEC, a copy of which can also be found on the Company's website.
Pixie Dust Technologies Reports First-Half Fiscal Year 2024 Financial Results